FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2906078889> ?p ?o ?g. }

• W2906078889 endingPage "e13666" @default.
• W2906078889 startingPage "e13666" @default.
• W2906078889 abstract "Numerous studies have investigated the associations between RARβ2, DAPK, hMLH1, p14, and p15 promoter hypermethylation and clinical progression of patients with breast cancer, however the results remained uncertain due to the small sample size. Therefore, we performed a meta-analysis to explore the role of RARβ2, DAPK, hMLH1, p14, and p15 promoter hypermethylation in the susceptibility and clinical progression of breast cancer.Eligible studies were obtained by searching Medicine, Embase, Web of knowledge, and Chinese National Knowledge Infrastructure (CNKI) databases. The odds ratios (OR) and 95% confidence intervals (CI) were calculated to evaluate the associations of RARβ2, DAPK, hMLH1, p14, and p15 promoter hypermethylation with breast cancer pathogenesis. Trial sequential analysis (TSA) was applied to observe the reliability of pooled results of RARβ2 gene, and obtain a conservative required information size (RIS).In primary screened 445 articles, 39 literatures with 4492 breast cancer patients were finally enrolled in the final meta-analysis. The results indicated that the frequency of RARβ2 promoter hypermethylation in case group was significantly higher than the frequency of control group (OR = 7.21, 95% CI = 1.54-33.80, P < .05). The RARβ2 promoter hypermethylation had a significant association with lymph node metastasis of breast cancer (OR = 2.13, 95% CI = 1.04-4.47, P < .05). And, the RARβ2 promoter hypermethylation was more common in the breast cancer patients of TNM III-IV stage than those patients of TNM I-II stage (OR = 1.85, 95% CI = 1.33-2.57, P < .05). In addition, the promoter hypermethylation of DAPK, hMLH1, and p14 genes were significantly associated with the susceptibility of breast cancer (for DAPK, OR = 4.93, 95% CI = 3.17-7.65; for hMLH1, OR = 1.84, 95% CI = 1.26-1.29; for p14, OR = 22.52, 95% CI = 7.00-72.41; for p15, OR = 2.13, 95% CI = 0.30-15.07).Our findings revealed that the RARβ2 promoter hypermethylation significantly increased the risk of breast cancer. In the meantime, the meta-analysis demonstrated that there were significant associations of RARβ2 promoter hypermethylation with lymph node metastasis and TNM-stage of breast cancer patients. In addition, DAPK, hMLH1, and p14 genes promoter hypermethylation were significantly associated with the susceptibility of breast cancer." @default.
• W2906078889 created "2019-01-01" @default.
• W2906078889 creator A5010388094 @default.
• W2906078889 creator A5080156747 @default.
• W2906078889 date "2018-12-01" @default.
• W2906078889 modified "2023-09-25" @default.
• W2906078889 title "Promoter hypermethylation of RARβ2, DAPK, hMLH1, p14, and p15 is associated with progression of breast cancer" @default.
• W2906078889 cites W1506411356 @default.
• W2906078889 cites W1535415765 @default.
• W2906078889 cites W1602145223 @default.
• W2906078889 cites W1965263399 @default.
• W2906078889 cites W1991982333 @default.
• W2906078889 cites W2003742874 @default.
• W2906078889 cites W2004644480 @default.
• W2906078889 cites W2021452615 @default.
• W2906078889 cites W2023798725 @default.
• W2906078889 cites W2027532999 @default.
• W2906078889 cites W2031330018 @default.
• W2906078889 cites W2035064373 @default.
• W2906078889 cites W2043826252 @default.
• W2906078889 cites W2044336867 @default.
• W2906078889 cites W2053434912 @default.
• W2906078889 cites W2054120792 @default.
• W2906078889 cites W2054974538 @default.
• W2906078889 cites W2060966049 @default.
• W2906078889 cites W2063517156 @default.
• W2906078889 cites W2068548616 @default.
• W2906078889 cites W2072228651 @default.
• W2906078889 cites W2072433546 @default.
• W2906078889 cites W2075803604 @default.
• W2906078889 cites W2083697259 @default.
• W2906078889 cites W2091553610 @default.
• W2906078889 cites W2096293845 @default.
• W2906078889 cites W2096996041 @default.
• W2906078889 cites W2100579820 @default.
• W2906078889 cites W2101979288 @default.
• W2906078889 cites W2107328434 @default.
• W2906078889 cites W2108421119 @default.
• W2906078889 cites W2110444464 @default.
• W2906078889 cites W2110486593 @default.
• W2906078889 cites W2113441506 @default.
• W2906078889 cites W2116475791 @default.
• W2906078889 cites W2120001940 @default.
• W2906078889 cites W2125228883 @default.
• W2906078889 cites W2125435699 @default.
• W2906078889 cites W2126930838 @default.
• W2906078889 cites W2128694990 @default.
• W2906078889 cites W2144991460 @default.
• W2906078889 cites W2148578116 @default.
• W2906078889 cites W2150000105 @default.
• W2906078889 cites W2152150614 @default.
• W2906078889 cites W2156132570 @default.
• W2906078889 cites W2157719382 @default.
• W2906078889 cites W2157823046 @default.
• W2906078889 cites W2159144282 @default.
• W2906078889 cites W2166445319 @default.
• W2906078889 cites W2169961966 @default.
• W2906078889 cites W2182224080 @default.
• W2906078889 cites W2203102867 @default.
• W2906078889 cites W2219978888 @default.
• W2906078889 cites W2230786904 @default.
• W2906078889 cites W2301414084 @default.
• W2906078889 cites W2409492609 @default.
• W2906078889 cites W2548538517 @default.
• W2906078889 cites W2763343039 @default.
• W2906078889 cites W2793046048 @default.
• W2906078889 cites W2793105416 @default.
• W2906078889 cites W2799822766 @default.
• W2906078889 cites W2800289222 @default.
• W2906078889 cites W3022903699 @default.
• W2906078889 cites W644130185 @default.
• W2906078889 cites W83644052 @default.
• W2906078889 cites W89028192 @default.
• W2906078889 doi "https://doi.org/10.1097/md.0000000000013666" @default.
• W2906078889 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6320171" @default.
• W2906078889 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30572486" @default.
• W2906078889 hasPublicationYear "2018" @default.
• W2906078889 type Work @default.
• W2906078889 sameAs 2906078889 @default.
• W2906078889 citedByCount "15" @default.
• W2906078889 countsByYear W29060788892019 @default.
• W2906078889 countsByYear W29060788892020 @default.
• W2906078889 countsByYear W29060788892021 @default.
• W2906078889 countsByYear W29060788892022 @default.
• W2906078889 countsByYear W29060788892023 @default.
• W2906078889 crossrefType "journal-article" @default.
• W2906078889 hasAuthorship W2906078889A5010388094 @default.
• W2906078889 hasAuthorship W2906078889A5080156747 @default.
• W2906078889 hasBestOaLocation W29060788891 @default.
• W2906078889 hasConcept C104317684 @default.
• W2906078889 hasConcept C121608353 @default.
• W2906078889 hasConcept C126322002 @default.
• W2906078889 hasConcept C143998085 @default.
• W2906078889 hasConcept C146357865 @default.
• W2906078889 hasConcept C150194340 @default.
• W2906078889 hasConcept C151730666 @default.
• W2906078889 hasConcept C156957248 @default.
• W2906078889 hasConcept C190727270 @default.

• next